The NTAP Francis S. Collins Scholars Program 2027 supports early-career clinician scientists pursuing neurofibromatosis type 1 (NF1) clinical and translational research.
Offered by the Neurofibromatosis Therapeutic Acceleration Program at Johns Hopkins University, it combines salary support, research funding, clinical training and mentorship. Its oncology relevance includes NF1-associated tumours and research into their detection, progression and treatment.
Eligibility Criteria
- Hold a health professional degree permitting patient care.
- Be in the final year of postdoctoral training or within seven years of the first faculty appointment.
- Commit 75–100% of professional effort for two to three years.
- Demonstrate commitment to patient-focused NF1 research and clinical care.
- Show previous research and clinical accomplishments.
- Have mentors covering research, NF1 clinical care and career development.
- Have access to the resources needed for the proposed work.
- Applications from around the world are encouraged, provided all requirements are met.
Funding Details
- Salary: Support for 75–100% effort, subject to the NIH salary cap.
- Research: Up to $25,000 annually.
- Travel: Up to $10,000 annually.
- Education: Up to $10,000 annually.
- Mentor stipend: $10,000 annually.
- Duration: Two to three years.
Deadline
- Application: December 7, 2026, at 11:59 p.m. EST.
- Notification: January 22, 2027.
- Funding starts: July 1, 2027.
Further Information
- Official programme page
- 2027 application guidelines
- Apply through ProposalCentral
- Contact: info@n-tap.org